The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

BRENTWOOD, Tenn. - Surgery Partners, Inc. (NASDAQ: NASDAQ:SGRY), a prominent operator of short-stay surgical facilities with ...

An itchy tattoo is common, especially just after you've had it done. Most of the time, the itching is caused by the healing process and is completely normal. There are some other things that might ...

Insignia Financial has opened its books to Bain Capital after it matched CC Capital Partners' revised takeover offer. It comes as the wealth giant reports several achievements, including growth in its ...

INSIGNIA Financial’s shares hit a three-year high on Thursday (Jan 23), driven by a revised takeover offer of A$3.07 billion (S$2.6 billion) from US-based Bain Capital, matching the bid of rival CC ...

Insignia Financial has announced total quarterly net inflows of $2.3 billion as well as a third bid from Bain Capital. In its quarterly results for the three months to 31 December, it said total net ...

“Clearly, Insignia has shown a preference for CC Capital, because Bain will presumably pull the business apart, while CC Capital has indicated they’ll leave management to run the busines ...

Ricardo Godoi reportedly hired a tattoo studio to ink his body in a hospital setting, where he ultimately died on the operating table Zoey Lyttle is a Society & Culture Writer-Reporter at PEOPLE.

Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...

The real estate arm of Boston’s Bain Capital LP’s and Atlanta’s Evergreen Medical Properties purchased the building at 2440 M St. NW in the District’s West End neighborhood for $45.5 ...

Bain Capital, a global private investment firm, has proposed to acquire a significant minority shareholding in Dhoot Transmission Private Limited (DTPL) and its associate company, Dhoot Holdings ...

Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said, a transaction that could ...